Piper Sandler Initiates Coverage On Aptose Biosciences with Overweight Rating, Announces $10 Price Target

Piper Sandler initiates coverage on Aptose Biosciences (NASDAQ:APTO) with a Overweight rating and a $10 price target.

Benzinga · 01/09/2020 15:48

Piper Sandler initiates coverage on Aptose Biosciences (NASDAQ:APTO) with a Overweight rating and a $10 price target.